The situation
Scientia Vascular had developed a novel neurovascular access platform and was entering a rapidly evolving competitive landscape. As new technologies emerged and incumbents repositioned, leadership needed the company's commercial story to support long-term category relevance — not just near-term momentum.
The challenge wasn't awareness or design execution.
It was determining how the company should show up, and keep showing up, as the category evolved.
The partnership
RŌG Health served as Scientia Vascular's strategic and creative partner for five years, ultimately as its agency of record.
In practice, that meant we were in the room for the commercial decisions that mattered — positioning, narrative, buyer logic, and how the company presented itself to surgeons, hospital systems, channel partners, and investors. Effectively everything commercially visible, we built: the messaging, the brand materials, the website, the market-facing presence that carried the company's story into the world.
This wasn't a single engagement. It was a sustained partnership through the years a company spends proving it deserves to win its category.
What the work focused on
Rather than starting with execution, the work started with clarity — then carried that clarity all the way through to what the market actually saw.
- The company's true point of distinction in the context of emerging competitors
- A narrative hierarchy that could adapt across buyer contexts without losing coherence
- Guardrails for messaging as the product portfolio and market footprint expanded
- The commercial materials and market presence that brought that narrative to life consistently, over years, across every channel
The result was a coherent commercial face, one that stayed defensible as the company scaled and raised.
The outcome
Scientia Vascular was acquired by Medtronic in 2026 for $550 million.
A great product is why an acquirer comes to the table. What a market sees — the story, the positioning, the presence — is part of what makes a company legible and credible to everyone it meets along the way. For five years, that was ours to build and protect.
Medtronic's leadership remarked on the work afterward, which is the outside read we would point to.
Why this matters for RŌG Health today
Partnerships like Scientia Vascular are where the RŌG point of view was formed: years beside leadership through the decisions about what holds up, what breaks, and what a company has to get right before it scales or sells.
Scientia had that as an embedded partner. Clarify, Plan and Build offer the same judgment, sized to where a company is now.
Three ways we help.
Work like this starts one of three ways:
Book a 30-minute call.
Tell us what you're working on and what's coming next. We'll tell you what we see and where we'd start. If we're not the right fit, we'll say so and point you to someone who is.
Talk to usPrefer to write first? Send us a note →